Epoetin alfa biosimilar (Wockhardt)

阿法依伯汀生物类似药 (Wockhardt)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameEpoetin alfa biosimilar (Wockhardt)

Drug Alias Name阿法依伯汀生物仿制药 (Wockhardt)Recombinant human erythropoietin biosimilarWepox

ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar

Mechanisms of ActionErythropoiesis stimulantsErythropoietin receptor agonists

TargetsErythropoietin receptor

Therapy Area/IndicationsAnemia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesWockhardt Ltd

China Registration ClassN/A

Active CompaniesWockhardt Ltd

Inactive CompaniesN/A

Active IndicationsAnemia

Inactive IndicationsN/A

ATC CodeB03XA01